Occupational hazard, exposure risk are key factors for prioritising COVID-19 vaccine: Dr Vardhan Read more
Bristol Myers Squibb presents data from True North trial of Zeposia (ozanimod) for ulcerative colitis Read more
Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study Read more
Vir Biotech research highlights mechanism to enhance monoclonal antibodies for inducing protective response Read more
Givinostat from Italfarmaco gets FDA rare pediatric disease designation in duchenne muscular dystrophy Read more